Publication
Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All
Farshad Guirakhoo, Scott Kitchener, Dennis Morrison, Remi Forrat, Karen McCarthy, Richard Nichols, Sutee Yoksan, Xiaochu Duan, Thomas H. Ermak, Niranjan Kanesa-Thasan, Philip Bedford, Jean Lang, Marie-Jose Quentin-Millet, Thomas P. Monath
Human Vaccines, March 2006, Taylor & Francis
DOI: 10.4161/hv.2.2.2555